April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Evaluation Of Anti-tubulin Agents For The Prevention Of Vasculopathy In A Rat Model Of Retinopathy Of Prematurity
Author Affiliations & Notes
  • Alireza Hosseini
    Physiological Sciences,
    Eastern Virginia Medical School, T. R. Lee Center for Ocular Pharmacology, Norfolk, Virginia
  • Jorge L. Jacot
    Pathology & Anatomy,
    Eastern Virginia Medical School, T. R. Lee Center for Ocular Pharmacology, Norfolk, Virginia
  • Frank A. Lattanzio, Jr.
    Physiological Sciences,
    Eastern Virginia Medical School, T. R. Lee Center for Ocular Pharmacology, Norfolk, Virginia
  • Karl A. Schellenberg
    Physiological Sciences,
    Eastern Virginia Medical School, T. R. Lee Center for Ocular Pharmacology, Norfolk, Virginia
  • Sandeep S. Samudre
    Physiological Sciences,
    Eastern Virginia Medical School, T. R. Lee Center for Ocular Pharmacology, Norfolk, Virginia
  • Patricia B. Williams
    Physiological Sciences,
    Eastern Virginia Medical School, T. R. Lee Center for Ocular Pharmacology, Norfolk, Virginia
  • Footnotes
    Commercial Relationships  Alireza Hosseini, OcuCure Therapeutics (R); Jorge L. Jacot, None; Frank A. Lattanzio, Jr., OcuCure Therapeutics (C); Karl A. Schellenberg, None; Sandeep S. Samudre, None; Patricia B. Williams, OcuCure Therepeutics (I, C, R)
  • Footnotes
    Support  provided partially by Richmond Eye & Ear Foundation
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3979. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alireza Hosseini, Jorge L. Jacot, Frank A. Lattanzio, Jr., Karl A. Schellenberg, Sandeep S. Samudre, Patricia B. Williams; Evaluation Of Anti-tubulin Agents For The Prevention Of Vasculopathy In A Rat Model Of Retinopathy Of Prematurity. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3979.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Retinopathy of prematurity (ROP) is a major cause of neonatal vision loss, accounting globally for approximately 50,000 cases annually of neonatal blindness. This study valuated the efficacy of anti-tubulin drugs, OC-10X and thalidomide, in the prevention of vasculopathy in a hyperoxia-hypoxia induced rat model of ROP.

Methods: : Rat pups from timed-pregnant Sprague-Dawley rats were randomized and placed in an oscillating oxygen chamber (FiO2 between 50% and 10%, cycling every 24 hours) for the first 14 days postnatally. On post-natal day 15 pups were exposed to room air (21% oxygen) and separated into three experimental groups (n=10 per group) during the vasoproliferative phase of ROP (post natal days 20 to 28). Experimental groups were: 1) Topical 1% OC-10X (tid), 2) Topical vehicle control (tid) and 3) Oral gavage of 100mg/kg thalidomide (qd). Rat pups were euthanized and enucleated at post-natal days 20, 24 or 28. The extent of retinal neovascularization was assessed by computer-assisted morphometry in fixed retinal whole mounts stained with ADPase. Retinal vasculopathy was evaluated using a quantitative severity scale (0-5) for the following parameters: 1) Area of avascularity, 2) Extent of vascular tufts, 3) Hemorrhages, and 4) Vessel tortuosity. While avascularity and vascular tortuosity demonstrates the model development, the extent of vascular tufts and hemorrhages are the areas expected to be effected by antiangiogenic treatments.

Results: : A demonstrable trend in reduction of the vascular tufts and incidence of retinal hemorrhage from both the OC-10X and thalidomide treated groups relative to vehicle was observed. While avascularity and vascular tortuosity confirmed the model development, the extent of vascular tufts and hemorrhages were the areas expected to be affected by antiangiogenic treatments.

Conclusions: : These preliminary findings suggest that structurally diverse anti-tubulin agents may impart beneficial effects on measurable end-points of ROP vasculopathy, such as vascular tufts and hemorrhage, which could have a clinical impact on improving visual outcome.

Keywords: retinopathy of prematurity • retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×